TABLE 4.
Samples | Groups | FB1 + DON | FB1 | FB2 | FB1 + FB2 + FB3 | DON | CONTROL |
Gizzard | High group | 260 ± 27.3a/10.2 ± 2.2a | 193 ± 15.9a | 128 ± 12.7a | 221 ± 13.0a | No data | 0 |
Moderate group | 129 ± 21.0b/11 ± 1.8a | 110 ± 13.9a | 67 ± 11.0b | 155 ± 12.3a | 10 ± 2.8a | 0 | |
Low group | 98 ± 10.2c/3 ± 2.7b | 69 ± 7.2b | 45 ± 6.5b | 110 ± 17.9b | No data | 0 | |
Lung | High group | 297 ± 20.3a/9 ± 6.1a | 216 ± 16.2a | 202 ± 13.6a | 253 ± 15.1a | No data | 0 |
Moderate group | 170 ± 41.2a/7 ± 3.1a | 131 ± 12.6a | 83 ± 7.9b | 162 ± 11.3a | 3 ± 1.3b | 0 | |
Low group | 123 ± 4.2b/10 ± 2.4a | 65 ± 10.5b | 65 ± 1.5c | 128 ± 12.4b | No data | 0 |
ap > 0.05 when the high FB1 + DON group or the high FB1 group, or the high FB2 group or the FB1 + FB2 + FB3 group was compared to the moderate group and the low groups in the same column.
bp < 0.05 when the high FB1 + DON group, or the high FB1 group, or the high FB2 group, or the FB1 + FB2 + FB3 group was compared to the moderate and the low group in the same column.
cp < 0.01 when the high FB1 + DON group, the high FB1 group, the high FB2 group, or the FB1 + FB2 + FB3 group was compared to the moderate group and the low group in the same column. The data were expressed as the mean ± SD.